Molecules that cause or prevent Parkinson's disease

PLoS Biology

Volumn 2, Issue 11, 2004, Pages

  Cookson, Mark R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; GENE PRODUCT; PARKIN; PROTEIN PINK1; UNCLASSIFIED DRUG; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE; SIGNAL PEPTIDE; SYNUCLEIN; UBIQUITIN PROTEIN LIGASE;

DEGENERATIVE DISEASE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MUTAGENESIS; PARKINSON DISEASE; PROTEIN AGGREGATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; BRAIN; DISEASE MODEL; GENETICS; METABOLISM; MOLECULAR EVOLUTION; MUTATION; NERVE CELL; PATHOLOGY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; EVOLUTION, MOLECULAR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MUTATION; NEURONS; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; SYNUCLEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 14044262193     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0020401     Document Type: Review

References (23)

1. Bandyopadhyay S, Cookson MR (2004) Evolutionary and functional relationships within the DJ1 superfamily. BMC Evol Biol 4: 6.
2. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
3. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: 9103-9108.
4. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97: 571-576.
5. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305: 1292-1295.
6. Dauer W, Przedborski S (2003) Parkinson's disease: Mechanisms and models. Neuron 39: 889-909.
7. Di Monte DA (2003) The environment and Parkinson's disease: Is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2: 531-538.
8. Dong Z, Ferger B, Paterna JC, Vogel D, Furler S, et al. (2003) Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci U S A 100: 12438-12443.
9. Greenamyre JT, Hastings TG (2004) Biomedicine. Parkinson's - Divergent causes, convergent mechanisms. Science 304: 1120-1122.
10. Hardy J, Langston JW (2004) How many pathways are there to nigral death? Ann Neurol 56: 316-318.
11. Martinat C, Shendelman SB, Jonason A, Leete T, Beal MF, et al. (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: An ES-derived cell model of primary parkinsonism. PLoS Biol 2: e327.
12. Olanow CW, Perl DP, DeMartino GN, McNaught KS (2004) Lewy-body formation is an aggresome-related process: A hypothesis. Lancet Neurol 3: 496-503.
13. Olzmann JA, Brown K, Wilkinson KD, Rees HD, Huai Q, et al. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem 279: 8506-8515.
14. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al. (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36: 1007-1019.
15. Shen J, Cookson MR (2004) Mitochondria and dopamine: New insights into recessive parkinsonism. Neuron 43: 301-304.
16. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregation formation. PLoS Biol 2: e362.
17. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, et al. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 293: 263-269.
18. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302: 841.
19. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
20. Volles MJ, Lansbury PT (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42: 7871-7878.
21. Yang Y, Nishimura I, Imai Y, Takahashi R, Lu B (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37: 911-924.
22. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, et al. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342-1348.
23. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, et al. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 97: 13354-13359.